OpGen, Inc.
$23.91+$9.75 (+64.36%)
OpGen, Inc.’s quoted price sits in the upper half of its reported 52-week range, 29.68% below the high.
OTC · MMTC · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Micro Imaging Technology, Inc.’s quoted price sits in the lower half of its reported 52-week range, 0.99% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Micro Imaging Technology, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Micro Imaging Technology, Inc. (MMTC) is a U.S.-based company focused on developing fluid monitoring solutions for the food safety and clinical industries. The firm is currently creating a rapid, laser-driven system designed to identify pathogenic bacteria efficiently. Additionally, MMTC collaborates with Northern Michigan University to explore novel methods for preparing pathogen samples, aiming to reduce test turnaround times to just 4 to 5 hours. Established in 1979, the company was formerly known as Electropure, Inc. before changing its name to Micro Imaging Technology, Inc. in November 2005. Its main offices are located in San Clemente, California.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:50 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$23.91+$9.75 (+64.36%)
OpGen, Inc.’s quoted price sits in the upper half of its reported 52-week range, 29.68% below the high.
$0.00$0.00 (0.0%)
OneLife Technologies Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Motus GI Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.8% below the high.
$0.00$0.00 (0.0%)
eFFECTOR Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.0% below the high.
$0.00$0.00 (0.0%)
BioELife Corp.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
$0.00$0.00 (0.0%)
HLK Biotech Holding Group, Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.46% below the high.
$0.00$0.00 (0.0%)
Ingen Technologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
$0.00$0.00 (0.0%)
Minerva Surgical, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.